Enovis Announces Planned CEO Succession Process

Core Viewpoint - Enovis Corporation announced the retirement of CEO Matt Trerotola, effective upon the appointment of his successor, as part of the company's succession planning process [1][2][3] Group 1: Leadership Transition - The Board of Directors is actively working with an executive search firm to find a growth-oriented MedTech leader to succeed Trerotola [1] - Trerotola will continue to serve as an employee and Executive Advisor for one year after the new CEO is appointed to ensure a smooth transition [2] - Trerotola expressed pride in the company's accomplishments and emphasized that now is the right time for leadership transition due to the company's strong position for continued growth [3] Group 2: Company Overview - Enovis Corporation is a leader in medical technology innovation, focusing on developing clinically differentiated solutions that improve patient outcomes [4] - The company is dedicated to continuous improvement and innovation, with a wide range of products and services aimed at enhancing active lifestyles in orthopedics and beyond [4]